Results 31 to 40 of about 550,806 (288)
Abstracts of the X Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 10)
The Spanish Group for Cancer Immuno-Biotherapies (GÉTICA) held the X Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 10) from 14 to 16 March 2024, in Seville (Spain).
Francisco Aya +8 more
doaj +1 more source
The lecture deals with the problem of immune response in cancer. Lecture for physicians of all specialties, pharmacists and biologists interested in the problem of immune response to cancer.
Cherniavsky VI
doaj
Evolutionary paradigm in cancer immunology*
The dynamical system theory in combination with experimental medical data can serve to improve our understanding of how the immune system works and fights the cancer.
Tsygvintsev Alexei
doaj +1 more source
Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells [PDF]
Acute inflammation is a complex and tightly regulated homeostatic process that includes leukocyte migration from the vasculature into tissues to eliminate the pathogen/injury, followed by a pro-resolving response promoting tissue repair.
Achuthan +115 more
core +1 more source
Abstracts of the XI Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 11)
The Spanish Group for Cancer Immuno-Biotherapies (GÉTICA) held the XI Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 11) from 13 to 15 March 2025, in Madrid (Spain).
Francisco Aya +8 more
doaj +1 more source
A Tumor-admixture Model to Interrogate Immune Cell–dependent Tumorigenesis
A rigorous determination of effector contributions of tumor-infiltrating immune cells is critical for identifying targetable molecular mechanisms for the development of novel cancer immunotherapies.
Jordan Noe +5 more
doaj +1 more source
Natural killer cells in placentation and cancer: Implications for hypertension during pregnancy [PDF]
Hypertension during pregnancy is the most common medical condition encountered during gestation. Despite this, knowledge of the mechanisms that underlie the disease and the development of new therapies are limited.
Cornelius, Denise C. +3 more
core +1 more source
Tumor derived Microvesicles enhance cross-processing ability of clinical grade Dendritic Cells [PDF]
Tumor cells release extracellular microvesicles (MVs) in the microenvironment to deliver biological signals to neighbouring cells as well as to cells in distant tissues.
Battisti, Federico +11 more
core +1 more source
ABSTRACT Purpose Metabolic syndrome (MetS) is a common complication in survivors of childhood acute lymphoblastic and myeloid leukemia (AL), and a major risk factor for premature cardiovascular disease, type‐2‐diabetes, and metabolic dysfunction‐associated steatotic liver disease (MASLD).
Visentin Sandrine +10 more
wiley +1 more source
Cancer immunology – development of novel anti-cancer therapies
The vast majority of tumours are characterised by high frequencies of genetic and epigenetic alterations resulting in tumour-specific antigens, which may, in principle, be recognised by cytotoxic T cells. Though early clinical immunotherapy trials have
Sacha I Rothschild +4 more
doaj +1 more source

